flurazepam dihydrochloride--dea*schedule iv item

Independent reference data for flurazepam dihydrochloride--dea*schedule iv item (CAS 1172-18-5), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Synonyms and trade names

Flurazepam hydrochloride; Flurazepam dihydrochloride; 1172-18-5; Benozil; Linzac; Lunipax; Somlan; Insumin dihydrochloride; NSC-78559; Ro 5-6901; Flurazepam hydrochloride civ; ID 480; 756RDM536M; Ro-5-6901; DTXSID3025334; NSC78559

GHS hazard classification

Reported hazard statements	H302 (100%), H373 (92.9%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H373 (92.9%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

What the public record says

flurazepam dihydrochloride--dea*schedule iv item · CAS 1172-18-5 · C21H23ClFN3O.2ClH. UNII 756RDM536M.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.